Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

39.92
Delayed Data
As of Sep 19
 -0.13 / -0.32%
Today’s Change
37.20
Today|||52-Week Range
44.54
+3.66%
Year-to-Date

Today’s Trading

Previous close40.05
Today’s open39.85
Day’s range39.70 - 39.92
Volume3,798,407
Average volume (3 months)2,832,966
Market cap$98.5B
Dividend yield6.23%
Data as of 09/19/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+14.74%
Earnings growth (next 5 years)+5.50%
Revenue growth (last year)+2.85%
P/E ratio50.7
Price/Sales2.52
Price/Book70.18

Competitors

 Today’s
change
Today’s
% change
BMYBristol-Myers Squibb+0.23+0.37%
NVONovo Nordisk-0.02-0.04%
LLYEli Lilly and Co-0.79-0.96%
CELGCelgene+0.63+0.44%
Data as of 09/19/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$0.83
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Emma Walmsley
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts